Anticipating a regional shift: Preparing the pharmaceutical industry for real-world evidence requirements across East Asia analogous to a Conditional Reimbursement List framework
Pharmacoeconomics and Policy · 2026-06 · 2 (2) · 55-59
DOI: 10.1016/j.pharp.2026.06.005 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmacoeconomics and Policy, 2026-06. Verfasst von Hong Li und 3 weiteren Autor:innen. Die Arbeit nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Li, H., Tsourougiannis, D., Wu, D. B., & Chang, C. (2026). Anticipating a regional shift: Preparing the pharmaceutical industry for real-world evidence requirements across East Asia analogous to a Conditional Reimbursement List framework. Pharmacoeconomics and Policy, 2(2), 55-59. https://doi.org/10.1016/j.pharp.2026.06.005
Vancouver
Li H, Tsourougiannis D, Wu DB, Chang C. Anticipating a regional shift: Preparing the pharmaceutical industry for real-world evidence requirements across East Asia analogous to a Conditional Reimbursement List framework. Pharmacoeconomics and Policy. 2026;2(2):55-59. doi:10.1016/j.pharp.2026.06.005
BibTeX
@article{Li2026,
author = {Li, Hong and Tsourougiannis, Dimitrios and Wu, David Bin-Chia and Chang, Chee-Jen},
title = {Anticipating a regional shift: Preparing the pharmaceutical industry for real-world evidence requirements across East Asia analogous to a Conditional Reimbursement List framework},
journal = {Pharmacoeconomics and Policy},
year = {2026},
volume = {2},
number = {2},
pages = {55--59},
doi = {10.1016/j.pharp.2026.06.005}
}
EUVIMED